低风险乳腺癌单次术前放疗(SPORT-CK)试验:一项2期研究的早期结果
这项单臂2期试验纳入25例≥60岁、单灶低风险乳腺浸润性导管癌(cT1N0、1-2级、ER+、Her2-)患者,接受单次20 Gy术前部分乳腺照射(VMAT)后72小时内行保乳手术±前哨淋巴结活检。中位随访60个月,无手术并发症,急性及晚期RTOG皮肤毒性几乎均为0-1级,医患美容评估均为好至优,无复发。作者认为术前单次PBI对老年低风险早期乳腺癌安全可行,需随机对照试验比较术前与辅助PBI。
要点
- 25例低风险早期乳腺癌患者接受单次20 Gy术前VMAT部分乳腺照射。
- 90天内无手术并发症,急性及晚期RTOG皮肤毒性几乎均为0-1级。
- 中位随访60个月无复发,美容结局医患评估均为好至优。
核心结论
- 术前单次部分乳腺照射对老年低风险早期乳腺癌患者是安全可行的治疗,无手术并发症,急性和晚期放疗毒性发生率极低,美容结局极佳。
- 需要随机对照试验在该患者人群中比较术前与辅助部分乳腺照射。
研究设计与样本
- 单臂2期试验,纳入25例≥60岁、单灶低风险乳腺浸润性导管癌(cT1N0、1-2级、ER+、Her2-)女性患者。
- 患者接受单次20 Gy术前部分乳腺照射,采用容积旋转调谐放疗(VMAT),放疗后72小时内行保乳手术±前哨淋巴结活检。
- 主要结局为手术并发症发生率和早期毒性,次要结局为12个月美容结局、慢性毒性和同侧乳腺肿瘤复发。
主要发现
- 中位年龄67岁,中位随访60个月。
- 前哨淋巴结活检阳性1/24例(4%)。
- 2例因切缘近或淋巴结阳性接受辅助放疗。
- 90天内无患者发生手术并发症;急性及晚期RTOG皮肤毒性几乎均为0-1级。
- 医师和患者的美容评估在所有病例中均为好至优,除1例患者在第三年自评美容结局为一般;无复发病例。
临床怎么用
- 作者认为术前单次部分乳腺照射对老年低风险早期乳腺癌患者是安全可行的治疗。
- 作者提出需要随机对照试验在该患者人群中比较术前与辅助部分乳腺照射。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Preoperative partial breast irradiation (PBI) is a novel technique that can be used in patients with early-stage breast cancer with the goal of limiting the irradiated breast volume, toxicity and number of fractions. The aim of this trial is to assess the toxicity, surgical, oncologic and cosmetic outcomes of preoperative PBI. MATERIALS AND METHODS: In this single-arm phase II trial, we enrolled women ≥ 60 years, with unifocal low-risk breast invasive ductal carcinoma (cT1N0, grade 1-2, ER+, Her2-). Patients were treated with a single fraction of 20 Gy of preoperative PBI using volumetric modulated arc therapy (VMAT). Patients then underwent breast-conserving surgery (BCS) +/- sentinel lymph node biopsy within 72 h of radiation. Primary outcomes were rate of surgical complications and early toxicity. Secondary outcomes were cosmesis at 12 months, chronic toxicity and ipsilateral breast tumor recurrence. RESULTS: Twenty-five patients were recruited with a median age of 67 years, and a median follow-up of 60 months. Sentinel biopsy was positive in 1 out of 24 patients (4 %). Two patients received adjuvant RT for close margins or positive lymph nodes. Within the first 90 days, none of the patients had surgical complications; almost all had grade 0 to 1 acute and late RTOG skin toxicity. The cosmetic outcome was rated between good and excellent in all cases by physicians and patients, except for one patient who self-rated her cosmesis as fair as of the third year. There were no recurrences. CONCLUSION: Preoperative single-fraction PBI is a safe and feasible treatment for elderly patients with low-risk early-stage breast cancer, with no surgical complications, very low rates of acute and late radiation toxicity, and excellent cosmetic outcomes. Randomized controlled trials are needed to compare preoperative to adjuvant PBI in this patient population.
引用
- Mahmoud D, Yassa M, Alvarado L, et al. Single pre-operative radiation therapy (SPORT-CK) trial for low-risk breast cancer: Early results of a phase 2 study. Radiother Oncol. 2024. PMID: 39218040. doi:10.1016/j.radonc.2024.110510
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。